{content}

Study list

Cappelli

Italy
|
2021-2023
  • General population
  • Infants (<1 year)
  • Children (1-11 years)
  • Adolescents (12-17 years)
  • Hospital
  • Emergency department
  • Influenza-like illness/Acute respiratory infection

Huygens

The Netherlands
|
2021-2022
  • Adults (18-64 years)
  • Elderly (≥65 years)
  • Fragile population
  • Immunocompromised host
  • Hospital
  • Outpatient clinic
  • SARS-CoV-2
  • Pharmacological intervention
  • Monoclonal antibodies
  • Sotrovimab
  • Tixagevimab/Cilgavimab
  • Casirivimab/Imdevimab

POSTCODE

United Kingdom
|
2021-2024
  • Adults (18-64 years)
  • General population
  • Elderly (≥65 years)
  • Hospital
  • Outpatient clinic
  • SARS-CoV-2
  • Post COVID-19 condition
  • Post-acute infection syndrome

BronchSTART

United Kingdom Ireland
|
2021-2026
  • General population
  • Infants (<1 year)
  • Children (1-11 years)
  • Hospital
  • Emergency department
  • Respiratory syncytial virus

Azevedo

Portugal
|
2021-2022
  • Adults (18-64 years)
  • General population
  • Elderly (≥65 years)
  • Hospital
  • Intensive care unit
  • SARS-CoV-2
  • Post COVID-19 condition
  • Post-acute infection syndrome

MEADOWSPRING

Argentina Belgium Brazil Denmark Germany Mexico Romania Switzerland Turkiye Ukraine
|
2021-2022
  • Adults (18-64 years)
  • Elderly (≥65 years)
  • Adolescents (12-17 years)
  • Hospital
  • Outpatient clinic
  • SARS-CoV-2
  • Post COVID-19 condition
  • Post-acute infection syndrome

Peghetti

Italy
|
2021-2023
  • Adults (18-64 years)
  • General population
  • Elderly (≥65 years)
  • SARS-CoV-2
  • Post COVID-19 condition
  • Post-acute infection syndrome
  • Non pharmacological intervention
  • Rehabilitation

BRAINSTORM

France
|
2021-2022
  • Adults (18-64 years)
  • General population
  • Elderly (≥65 years)
  • Hospital
  • SARS-CoV-2
  • Post COVID-19 condition
  • Post-acute infection syndrome

Lindsay

United Kingdom
|
2021
  • Adults (18-64 years)
  • Fragile population
  • SARS-CoV-2
  • Post COVID-19 condition
  • Post-acute infection syndrome

Post-Covid UKF

Germany
|
2021
  • Adults (18-64 years)
  • General population
  • Hospital
  • Outpatient clinic
  • SARS-CoV-2
  • Post COVID-19 condition
  • Post-acute infection syndrome

SubFSC19-KN

Germany
|
2021-2024
  • Adults (18-64 years)
  • General population
  • Elderly (≥65 years)
  • Outpatient clinic
  • SARS-CoV-2
  • Post COVID-19 condition
  • Post-acute infection syndrome

LUNGTERMcov

Switzerland
|
2021-2023
  • Adults (18-64 years)
  • General population
  • Elderly (≥65 years)
  • Hospital
  • Outpatient clinic
  • Intensive care unit
  • SARS-CoV-2
  • Post COVID-19 condition
  • Post-acute infection syndrome

COMEBAC 2

France
|
2021-2022
  • Adults (18-64 years)
  • General population
  • Elderly (≥65 years)
  • Hospital
  • SARS-CoV-2
  • Post COVID-19 condition
  • Post-acute infection syndrome

RSV GOLD—ICU Network study

Bolivia Cameroon The Gambia Ghana Haiti Mozambique Nepal Nigeria Sudan Tanzania The Netherlands
|
2021-2023
  • General population
  • Infants (<1 year)
  • Children (1-11 years)
  • Hospital
  • Emergency department
  • Respiratory syncytial virus
  • Influenza-like illness/Acute respiratory infection

Ballmann

Germany
|
2021-2022
  • Adults (18-64 years)
  • General population
  • Children (1-11 years)
  • Adolescents (12-17 years)
  • Community
  • SARS-CoV-2
  • Post COVID-19 condition
  • Post-acute infection syndrome

Hedman

Sweden
|
2021-2022
  • Adults (18-64 years)
  • General population
  • Elderly (≥65 years)
  • Outpatient clinic
  • SARS-CoV-2
  • Post COVID-19 condition
  • Post-acute infection syndrome

Steinmetz

Germany
|
2021
  • General population
  • Outpatient clinic
  • SARS-CoV-2
  • Post COVID-19 condition
  • Post-acute infection syndrome

COVIMMUNE-Clin

Germany
|
2021
  • Adults (18-64 years)
  • General population
  • Elderly (≥65 years)
  • SARS-CoV-2
  • Post COVID-19 condition
  • Post-acute infection syndrome

D’Hondt

Belgium
|
2021-2022
  • Adults (18-64 years)
  • General population
  • Elderly (≥65 years)
  • Outpatient clinic
  • SARS-CoV-2
  • Post COVID-19 condition
  • Post-acute infection syndrome

PCS_Fettoxidation

Germany
|
2021-2024
  • Adults (18-64 years)
  • General population
  • Elderly (≥65 years)
  • Outpatient clinic
  • SARS-CoV-2
  • Post COVID-19 condition
  • Post-acute infection syndrome
  • Non pharmacological intervention
  • Rehabilitation

Vestesson

United Kingdom
|
2021-2022
  • Adults (18-64 years)
  • General population
  • Elderly (≥65 years)
  • Children (1-11 years)
  • Adolescents (12-17 years)
  • Primary care
  • Influenza-like illness/Acute respiratory infection
  • Pharmacological intervention
  • Telehealth

Weidlich

Germany
|
2021-2022
  • Adults (18-64 years)
  • People at high risk of STIs
  • Men who have sex with men
  • Non-hospital health centre
  • STD/STI clinic
  • Chlamydia trachomatis
  • Neisseria gonorrhoeae
  • Non pharmacological intervention
  • RT-PCR

DisCOVID

France
|
2021-2024
  • Adults (18-64 years)
  • General population
  • Elderly (≥65 years)
  • Hospital
  • SARS-CoV-2
  • Post COVID-19 condition
  • Post-acute infection syndrome

ERiDenF

France
|
2021-2023
  • Pregnant women
  • Hospital
  • Arbovirus
  • Dengue virus
  • Vector-borne disease